We have selected four solid stocks that have striking earnings growth and positive estimate revisions.
Bull of the Day: Vertex Pharma (VRTX)
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.) * AstraZeneca plc (NYSE: AZN) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * Bio-Rad Laboratories, Inc. Class A …
The art of biotech investing requires a great deal of scientific knowledge, awareness of financials, and patience in waiting for clinical trials to come to fruition. Today, let's examine two of the best biotech stocks in the industry; both are companies making rapid progress in treating patients with significant medical needs. Compugen (NASDAQ: CGEN) specializes in clinical-stage cancer immunotherapies, which have proprietary algorithms used to detect specific sequences within protein receptors that regulate the immune system and inhibit autoimmune activity.
Vertex (VRTX) delivered earnings and revenue surprises of 39.89% and 19.60%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Health care stocks, as represented by the Health Care Select Sector SPDR ETF (XLV), have outperformed the broader market, providing investors with a total return of 16.3% compared to the S&P 500's total return of 5.9% over the past 12 months. In 2020, health care stocks have recouped nearly all of their losses since their March plunge while the broader market continues to suffer from the global coronavirus pandemic. The market performance numbers and the statistics in the tables in this story are as of May 20.
Bet on five stocks that are likely to outdo earnings estimates.
As optimism surrounding a coronavirus vaccine and consumer activity begin to pick up, Wall Street is expected to trade higher.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarte…
VRTX vs. ILMN: Which Stock Is the Better Value Option?
Biotechs are not as broadly and deeply affected by COVID-19 disruption and now lead the market as the economy begins the recovery process.Healthcare has attracted growing investor interest due to the sector's ability to recover quickly as well as benefit from…
While the coronavirus pandemic has disrupted the global economy, Netflix, Nvidia and ServiceNow are among 22 stocks expecting 25%-150% growth in 2020.
As Amazon and Netflix show strength in the coronavirus stock market, tech giants Microsoft, AMD and Tesla get ready to report earnings.
Is (VRTX) Outperforming Other Medical Stocks This Year?
In the latest market rally driven by hopes surrounding potential coronavirus vaccines and reopening of the economy, the S&P 500 reclaimed its 3,000 level and is poised to rise further.
Vertex Pharmaceuticals (VRTX) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Individual stock picking is increasingly important.Continue to concentrate on healthcare and technology.Here are the top stocks to buy now.
Dow Jones futures rose and Nasdaq futures fell as coronavirus stock market rally sector rotation continues. China OK'd a national security law for Hong Kong.
Vertex (VRTX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street poised to gain after Powell expressed confidence that the U.S. economy will recover beginning summer.
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) • Bio-Rad Laboratories, Inc. Cla…
VRTX earnings call for the period ending March 31, 2020.
XBI soared nearly 58% off its March low.Amgen climbed 38% off March low almost back to an ATH.AbbVie also up ~37%, but a long way from the highs hit in 2018.In the video, we discuss larger context for these moves and probable patterns going forward for the la…
The answer is yes. There's no need to build any suspense. Vertex Pharmaceuticals (NASDAQ: VRTX) is definitely a great stock to buy right now, in my view. I've owned the biotech stock for a couple of years.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the m…
Motley Fool co-founder David Gardner revisits three Five-Stock Samplers and offers up lessons he learned to help you invest better.
Half of this month is already over, yet Wall Street is in green defying the well-known financial-world adage "Sell in May and go away."
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology
The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals
Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
Uncle Sam could be sending more money your way in the not-too-distant future. Buying these stocks will put the extra cash to good use.